4-{[1,1'-biphenyl]-4-yl}-2-[(difluoromethyl)sulfanyl]pyrimidine

Catalog No.: 
ACWKIW724
CAS No.: 
477854-94-7
Molecular Formula: 
C17H12F2N2S
Molecular Weight: 
314.36
4-{[1,1'-biphenyl]-4-yl}-2-[(difluoromethyl)sulfanyl]pyrimidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg90%$113.00InquiryInquiry
1g90%$324.00InquiryInquiry
5g90%$1588.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-{[1,1'-biphenyl]-4-yl}-2-[(difluoromethyl)sulfanyl]pyrimidine
IUPAC Name4-([1,1'-biphenyl]-4-yl)-2-((difluoromethyl)thio)pyrimidine
Molecular FormulaC17H12F2N2S
Molecular Weight314.36
SMILESFC(SC1=NC=CC(C2=CC=C(C3=CC=CC=C3)C=C2)=N1)F
InChI KeyLLRPHNLQRBLTBE-UHFFFAOYSA-N
Synonym4-[1,1'-BIPHENYL]-4-YL-2-[(DIFLUOROMETHYL)SULFANYL]PYRIMIDINE;4-[1,1'-BIPHENYL]-4-YL-2-PYRIMIDINYL DIFLUOROMETHYL SULFIDE;Pyrimidine, 4-[1,1'-biphenyl]-4-yl-2-[(difluoromethyl)thio]-
CAS No.477854-94-7

Synthetic Route by SureRoute

1. ACWKIW724 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACSVLI572 route compound structure diagram
    ACSVLI5725122-94-1In Stock
  4. Then
  5. ACWKIW724 route product structure diagram
    ACWKIW724477854-94-7
Inquiry

2. ACWKIW724 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACQROT208 route compound structure diagram
    ACQROT20898-80-6In Stock
  4. Then
  5. ACWKIW724 route product structure diagram
    ACWKIW724477854-94-7
Inquiry

3. ACWKIW724 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACWKIW724 route product structure diagram
    ACWKIW724477854-94-7
Inquiry

Comments (0)